Cellectis Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	25.73	38.6	59.56	22.99	21.43	33.72	56.44	62.57	31.14	14.98
Revenue Growth (YoY)	-33.35%	-35.20%	159.09%	7.27%	-36.43%	-40.27%	-9.78%	100.95%	107.90%	-
Cost of Revenue	1.77	1.84	1.95	11.39	2.74	2.62	0	0	0	0
Gross Profit	23.95	36.75	57.61	11.6	18.69	31.1	56.44	62.57	31.14	14.98
Selling, General & Admin	17.49	22.88	22.51	43.02	47.25	44.75	43.41	30.22	15.44	22.4
Research & Development	97.5	117.84	77.05	92.04	76.57	79.23	78.46	58.15	16.96	21
Other Operating Expenses	-1.38	-0.49	0.36	0.09	-0.03	-0.23	1.88	5.17	4.92	2.79
Operating Expenses	113.62	140.23	99.92	135.15	123.78	123.75	123.75	93.55	37.31	46.2
Operating Income	-89.67	-103.48	-42.31	-123.55	-105.09	-92.65	-67.3	-30.98	-6.17	-31.22
Interest Expense / Income	17.82	6.49	16.12	3.63	3.81	18.29	7.1	1.88	0.62	0.92
Other Expense / Income	-1.43	4.23	22.65	-25.09	-30.21	-11.58	-7.15	-10.06	-6.82	33.07
Pretax Income	-106.05	-114.2	-81.07	-102.09	-78.69	-99.37	-67.26	-22.8	0.02	-65.21
Income Tax	0.09	0	0	0	0	0	0	0	0	0
Net Income	-106.14	-114.2	-81.07	-102.09	-78.69	-99.37	-67.26	-22.8	0.02	-65.21
Shares Outstanding (Basic)	46	45	42	42	42	35	35	34	26	-
Shares Outstanding (Diluted)	-	-	-	-	-	-	-	35	26	-
Shares Change	0.20%	7.04%	0.13%	0.06%	20.01%	0.44%	1.90%	31.80%	-	-
EPS (Basic)	-2.33	-2.55	-1.91	-2.41	-1.93	-2.78	-1.91	-0.67	-	-3.15
EPS (Diluted)	-2.33	-2.55	-1.91	-2.41	-1.93	-2.78	-1.91	-0.67	-	-3.15
Free Cash Flow	-89.88	-123.11	-124.34	-81.64	-71.59	-47.55	-46.38	-0.61	48.75	-22.86
Free Cash Flow Per Share	-1.97	-2.71	-2.93	-1.92	-1.69	-1.35	-1.32	-0.02	1.87	-
Gross Margin	93.11%	95.22%	96.72%	50.45%	87.22%	92.23%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-348.55%	-268.11%	-71.03%	-537.42%	-490.35%	-274.80%	-119.24%	-49.52%	-19.83%	-208.49%
Profit Margin	-412.59%	-295.87%	-136.11%	-444.07%	-367.18%	-294.73%	-119.15%	-36.44%	0.08%	-435.41%
Free Cash Flow Margin	-349.37%	-318.95%	-208.75%	-355.12%	-334.03%	-141.02%	-82.17%	-0.98%	156.56%	-152.65%
EBITDA	-69.8	-93.56	-57.12	-91.59	-72.5	-77.7	-57.94	-18.98	2.26	-61.64
EBITDA Margin	-271.34%	-242.39%	-95.90%	-398.37%	-338.29%	-230.47%	-102.66%	-30.34%	7.25%	-411.56%
Depreciation & Amortization	18.44	14.16	7.83	6.88	2.38	3.37	2.21	1.94	1.61	2.65
EBIT	-88.24	-107.71	-64.96	-98.46	-74.88	-81.07	-60.15	-20.92	0.64	-64.29
EBIT Margin	-343.00%	-279.07%	-109.05%	-428.27%	-349.38%	-240.47%	-106.57%	-33.44%	2.07%	-429.28%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).